Bank of Montreal Can acquired a new stake in shares of Integer Holdings Co. (NYSE:ITGR – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 3,382 shares of the medical equipment provider’s stock, valued at approximately $301,000.
A number of other hedge funds also recently made changes to their positions in the company. Portside Wealth Group LLC acquired a new stake in shares of Integer during the second quarter worth approximately $713,000. Truist Financial Corp grew its position in shares of Integer by 1.6% during the second quarter. Truist Financial Corp now owns 44,366 shares of the medical equipment provider’s stock worth $3,931,000 after buying an additional 720 shares in the last quarter. Keybank National Association OH grew its position in shares of Integer by 3.8% during the second quarter. Keybank National Association OH now owns 6,487 shares of the medical equipment provider’s stock worth $575,000 after buying an additional 235 shares in the last quarter. Cooke & Bieler LP grew its position in shares of Integer by 84.0% during the second quarter. Cooke & Bieler LP now owns 386,920 shares of the medical equipment provider’s stock worth $34,285,000 after buying an additional 176,590 shares in the last quarter. Finally, Strs Ohio grew its position in shares of Integer by 83.3% during the second quarter. Strs Ohio now owns 1,100 shares of the medical equipment provider’s stock worth $97,000 after buying an additional 500 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.
Insider Activity at Integer
In related news, Director Donald J. Spence sold 6,500 shares of Integer stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $82.32, for a total transaction of $535,080.00. Following the sale, the director now directly owns 18,781 shares in the company, valued at $1,546,051.92. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.84% of the company’s stock.
Integer Stock Performance
Integer (NYSE:ITGR – Get Free Report) last posted its earnings results on Thursday, October 26th. The medical equipment provider reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.22. The company had revenue of $404.69 million for the quarter, compared to analysts’ expectations of $376.70 million. Integer had a return on equity of 10.27% and a net margin of 5.30%. The firm’s quarterly revenue was up 18.1% compared to the same quarter last year. During the same period last year, the business posted $0.95 earnings per share. On average, research analysts predict that Integer Holdings Co. will post 4.59 EPS for the current year.
Analyst Ratings Changes
A number of research firms have recently weighed in on ITGR. Wells Fargo & Company raised their price target on shares of Integer from $87.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Friday, July 28th. Benchmark lifted their price objective on shares of Integer from $90.00 to $105.00 and gave the stock a “buy” rating in a report on Friday, July 28th. TheStreet raised shares of Integer from a “c+” rating to a “b” rating in a report on Thursday, July 27th. KeyCorp lifted their price objective on shares of Integer from $96.00 to $105.00 and gave the stock an “overweight” rating in a report on Friday, July 28th. Finally, StockNews.com assumed coverage on shares of Integer in a report on Thursday, October 5th. They issued a “hold” rating for the company. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $93.83.
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.
- Five stocks we like better than Integer
- Are Stock Buybacks Good for the Average Investor?
- The most upgraded stocks in November have two things in common
- Where to Find Earnings Call Transcripts
- Monday.com rocked earnings like it’s the weekend
- How to Invest in Toy Stocks
- Plan to own one retailer? Make it this one
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.